bg-rating-rationales

Entity-Specific Rating Rationales

30 Oct 2025

Biocon Limited: Ratings reaffirmed

Biocon Limited: Ratings reaffirmed

30 Aug 2024

Biocon Limited: Ratings reaffirmed for bank facilities; rating reaffirmed and withdrawn for commercial paper programme

Biocon Limited: Ratings reaffirmed for bank facilities; rating reaffirmed and withdrawn for commercial paper programme

04 Aug 2023

Biocon Limited: Ratings reaffirmed; removed from rating watch with developing implications; assigned Stable outlook for the long-term rating; short term rating reaffirmed

Biocon Limited: Ratings reaffirmed; removed from rating watch with developing implications; assigned Stable outlook for the long-term rating; short term rating reaffirmed

17 Nov 2022

Biocon Limited: Long-term rating continues to be on watch with developing implications; short-term rating removed from watch with developing implications and reaffirmed; Rating assigned for CP programme

Biocon Limited: Long-term rating continues to be on watch with developing implications; short-term rating removed from watch with developing implications and reaffirmed; Rating assigned for CP programme

bg-rating-crediet-reports

Entity-Specific Credit Perspective Reports

11 Oct 2024

Biocon Limited

Biocon Limited (Non-SF)

04 Sep 2023

Biocon Limited

Biocon Limited (Non-SF)

06 Jan 2023

Biocon Limited

Biocon Limited (Non-SF)

Ratings

Description
Short Term
Medium Term
Long Term
Issuer
Long-term/Short-term – unallocated [ICRA]A1+ -- [ICRA]AA+(Stable) --
Commercial Paper Withdrawn -- -- --

Our Analysts

Analyst 1

Nishant Misra

Analyst 2

Mythri Macherla

Sector Head

Shamsher Dewan
bg-rating-research

Most Trending Research Reports


View More
bg-rating-rationales

Rating Rationales

icon-download

View More

Indian Banking Sector- Banking Outlook: Growth Revival amid Asset Quality and Regulatory Shifts

Mr Karthik Srinivasan,Mr Anil Gupta,Mr Sachin Sachdeva

12 Nov 2025 04:00 PM
Register now 6 days Left

Credit Quality Trends and Performance of ICRA-Assigned Ratings in H1 FY2026

Mr. K Ravichandran,Mr. Pratik Singhania

01 Oct 2025 04:00 PM

The Indian Pharmaceutical Industry- Industry at a Crossroads: Navigating Global Challenges and Local Opportunities

Ms. Kinjal Shah,Mr. Deepak Jotwani

18 Sep 2025 04:00 PM

PPT Icon PPT

Podcast

View More

Media Release



View More
Ask Our Industry Analyst Get in touch with our Business Representative
Please enter your name
Please enter your mobile number
Please enter your email id
Please enter your company name
Name should not be greater than 50 characters
Please choose sector
Please enter your query
Query to have atleast ten characters
Query should not be greater than 1,000 characters
Please verify you are not a Robot.